In an effort to develop a male birth control, The National Institutes of Health, or NIH, has begun clinic trials for a male contraceptive gel known as the brand name Nestorone, or NES/T, according to a press release from the National Institute of Child Health and Human Development, or NICHD. The NIH is seeking roughly 420 healthy couples who want to be part of the study.
The study will evaluate the contraceptive gel, which was created by the Population Council and NICHD over a span of more than a decade, to see how well it prevents pregnancy. The gel consists of the progestin compound segesterone acetate, as well as testosterone. It is designed to be absorbed through the skin.
0 comments :
Post a Comment